RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 25

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

312

HTML

1631

Figures (1-3)

237

Tables (1-3)

181

Sum=2361

Jul 7, 2007 (publication date) through Nov 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jul 7, 2007; 13(25): 3517-3522
Published online Jul 7, 2007. doi: 10.3748/wjg.v13.i25.3517

Table 2 The apoptosis rate of 5 groups with FACS (%) (mean ± SEM)

Group	Apoptosis rate (%)	P
1 RhoA,C-siRNA	19.07 ± 1.78	Compared with any group (P < 0.01 or P < 0.05)
2 RhoA-siRNA	7.13 ± 0.21	Compared with 4 or 5 group (P < 0.05), compared with 3 group (P > 0.05)
3 RhoC-siRNA	8.11 ± 0.17	Compared with 4 or 5 group (P < 0.05)
4 siRNA	1.23 ± 0.11	Compared with any group (P < 0.01 or P < 0.05)
5 LY294002	9.44 ± 1.28	Compared with 4 group (P < 0.01)

Citation: Sun HW, Tong SL, He J, Wang Q, Zou L, Ma SJ, Tan HY, Luo JF, Wu HX. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway. World J Gastroenterol 2007; 13(25): 3517-3522
URL: https://www.wjgnet.com/1007-9327/full/v13/i25/3517.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i25.3517